CareDx completes sale of Lab Products business to Eurobio Scientific for $171.2 million cash

CareDx, Inc.

CareDx, Inc.

CDNA

0.00
  • CareDx closed the sale of its Lab Products business to Eurobio Scientific on June 30, 2026.
  • Received $171.2 million in cash at closing, subject to customary post-closing adjustments.
  • Deal shifts focus to U.S. precision medicine testing services, patient solutions, digital offerings; operating model simplified.
  • Additional financial impact, including pro forma results, expected on the second-quarter 2026 earnings call.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareDx Inc. published the original content used to generate this news brief on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.